Influence of the diketonato ligand on the cytotoxicities of [Ru(eta(6)-p-cymene)-(R(2)acac)(PTA)](+) complexes (PTA=1,3,5-triaza-7-phosphaadamantane)


Autoria(s): Vock, Carsten A.; Renfrew, Anna K.; Scopelliti.R; Lucienne.J-J; Paul J.D
Data(s)

2008

Resumo

A series of compounds of general formula [Ru(eta(6)-p-cymene) (R(2)acac)(PTA)][X] (R(2)acac = Me(2)acac, tBu(2)acac, Ph(2)acac, Me(2)acac-Cl; PTA = 1,3,5-triaza-7-phosphaadamantane; X = BPh4, BF4), and the precursor to the Me2acac-Cl derivative [Ru(eta(6)-p-cymene)(Me(2)acac-Cl)Cl], have been prepared and characterised spectroscopically. Five of the compounds have also been characterised in the solid state by X-ray crystallography. The tetrafluoroborate salts are water-soluble, quite resistant to hydrolysis, and have been evaluated for cytotoxicity against A549 lung carcinoma and A2780 human ovarian cancer cells. The compounds are cytotoxic towards the latter cell line, and relative activities are discussed in terms of hydrolysis (less important) and lipophilicity, which appears to exert the dominating influence.

Identificador

http://serval.unil.ch/?id=serval:BIB_DA85235D88E7

isbn:1434-1948

doi:10.1002/ejic.200701291

isiid:000255226800014

Idioma(s)

en

Fonte

European Journal of Inorganic Chemistry, no. 10, pp. 1661-1671

Palavras-Chave #bioorganometallics; anticancer drugs; metal-based drugs; ruthenium; X-ray structure; Ruthenium(Ii)-Arene Pta Complexes; Arene Complexes; Metal-Complexes; In-Vitro; Anticancer Drugs; Antitumor Drugs; Chemistry; Agents; Chemotherapy; Hydrolysis
Tipo

info:eu-repo/semantics/article

article